Randal W Scott - Net Worth and Insider Trading

Randal W Scott Net Worth

The estimated net worth of Randal W Scott is at least $421,955 dollars as of 2024-11-05. Randal W Scott is the Director of BridgeBio Pharma Inc and owns about 9,000 shares of BridgeBio Pharma Inc (BBIO) stock worth over $229,140. Randal W Scott is the Director of Talis Biomedical Corp and owns about 114,838 shares of Talis Biomedical Corp (TLIS) stock worth over $191,779. Randal W Scott is also the Executive Chairman of Invitae Corp and owns about 3,450,669 shares of Invitae Corp (NVTAQ) stock worth over $1,035. Besides these, Randal W Scott also holds Genomic Health Inc (GHDX) . Details can be seen in Randal W Scott's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Randal W Scott has not made any transactions after 2024-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Randal W Scott

To

Randal W Scott Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Randal W Scott owns 3 companies in total, including BridgeBio Pharma Inc (BBIO) , Invitae Corp (NVTAQ) , and Talis Biomedical Corp (TLIS) .

Click here to see the complete history of Randal W Scott’s form 4 insider trades.

Insider Ownership Summary of Randal W Scott

Ticker Comapny Transaction Date Type of Owner
BBIO BridgeBio Pharma Inc 2024-06-04 director
NVTAQ Invitae Corp 2019-08-26 director & 10 percent owner & Chairman and CEO
TLIS Talis Biomedical Corp 2021-05-17 director

Randal W Scott Latest Holdings Summary

Randal W Scott currently owns a total of 4 stocks. Among these stocks, Randal W Scott owns 9,000 shares of BridgeBio Pharma Inc (BBIO) as of June 4, 2024, with a value of $229,140 and a weighting of 54.3%. Randal W Scott owns 114,838 shares of Talis Biomedical Corp (TLIS) as of May 17, 2021, with a value of $191,779 and a weighting of 45.45%. Randal W Scott also owns 3,450,669 shares of Invitae Corp (NVTAQ) as of August 26, 2019, with a value of $1,035 and a weighting of 0.25%. The other 1 stocks Genomic Health Inc (GHDX) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Randal W Scott

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BBIO BridgeBio Pharma Inc 2024-06-04 9,000 25.46 229,140
TLIS Talis Biomedical Corp 2021-05-17 114,838 1.67 191,779
NVTAQ Invitae Corp 2019-08-26 3,450,669 0.00 1,035
GHDX Genomic Health Inc 2012-07-11 0 63.44 0

Holding Weightings of Randal W Scott


Randal W Scott Form 4 Trading Tracker

According to the SEC Form 4 filings, Randal W Scott has made a total of 6 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in BridgeBio Pharma Inc is the sale of 2,500 shares on June 4, 2024, which brought Randal W Scott around $75,800.

According to the SEC Form 4 filings, Randal W Scott has made a total of 2 transactions in Talis Biomedical Corp (TLIS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Talis Biomedical Corp is the acquisition of 1,333 shares on May 17, 2021, which cost Randal W Scott around $202,600.

According to the SEC Form 4 filings, Randal W Scott has made a total of 0 transactions in Invitae Corp (NVTAQ) over the past 5 years. The most-recent trade in Invitae Corp is the sale of 40,000 shares on August 26, 2019, which brought Randal W Scott around $983,600.

More details on Randal W Scott's insider transactions can be found in the Insider Trading History of Randal W Scott table.

Insider Trading History of Randal W Scott

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Randal W Scott Trading Performance

GuruFocus tracks the stock performance after each of Randal W Scott's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randal W Scott is 0.22%. GuruFocus also compares Randal W Scott's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randal W Scott within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Randal W Scott's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Randal W Scott

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.57 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -4.29 LIMIT LIMIT LIMIT LIMIT LIMIT

Randal W Scott Ownership Network

Ownership Network List of Randal W Scott

No Data

Ownership Network Relation of Randal W Scott

Insider Network Chart

Randal W Scott Owned Company Details

What does BridgeBio Pharma Inc do?

Who are the key executives at BridgeBio Pharma Inc?

Randal W Scott is the director of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include 10 percent owner Kkr Genetic Disorder L.p. , director & See Remarks Neil Kumar , and See Remarks Brian C Stephenson .

BridgeBio Pharma Inc (BBIO) Insider Trades Summary

Over the past 18 months, Randal W Scott made 5 insider transaction in BridgeBio Pharma Inc (BBIO) with a net sale of 12,000. Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 182,045 shares made by Neil Kumar , a net sale of 73,947 shares made by Brian C Stephenson , and a net sale of 8,745 shares made by Hannah Valantine .

In summary, during the past 3 months, insiders sold 5,831,544 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 5,831,544 shares. During the past 18 months, 7,676,737 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,676,737 shares.

BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BridgeBio Pharma Inc Insider Transactions

No Available Data

Randal W Scott Mailing Address

Above is the net worth, insider trading, and ownership report for Randal W Scott. You might contact Randal W Scott via mailing address: 171 Main Street #225, Los Altos Ca 94022.